1
|
Dreser A, Hegewisch-Taylor J, Cortés-Ortiz MA, Levy-Hara G. Progress and challenges in the implementation of antimicrobial stewardship programs in 50 hospitals in Mexico. J Glob Antimicrob Resist 2025; 43:40-50. [PMID: 40073975 DOI: 10.1016/j.jgar.2025.02.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2024] [Revised: 02/06/2025] [Accepted: 02/25/2025] [Indexed: 03/14/2025] Open
Abstract
OBJECTIVES Antimicrobial stewardship programs (ASP) aim to improve the quality of medical prescribing and contain antimicrobial resistance (AMR). There is little information on the implementation of ASP in hospitals in Mexico. This study aimed to characterize ASP in a sample of hospitals in Mexico and to identify the facilitators and barriers perceived in their implementation, including the COVID-19 pandemic. METHODS A self-assessment electronic survey was adapted from the CDC and WHO ASP's core elements, considering ASP organization, structure, education, guidelines, interventions, surveillance, monitoring, and reporting processes. The survey was addressed to ASP team leaders in a sample of public and private hospitals carrying out regular antimicrobial stewardship activities in Mexico in 2021 and 2022. RESULTS Fifty hospitals participated: 32 (64%) public and 18 (36%) private. Fifty-two percent of hospitals had an official ASP document, 12% allocated protected time for ASP professionals, and 34% had an annual plan. Most hospitals had an ASP committee (68%); only 14% allocated funding. Most interventions were restrictive (68%); 61% of hospitals prepared cumulative antibiograms periodically, 54% monitored antimicrobial consumption (DDD/DOT), 44% monitored adherence to guidelines, and 24% monitored the implementation of interventions. The main barriers identified were work overload, insufficient human resources, and hospital reconversion due to COVID-19 (particularly in public hospitals), while the support of hospital authorities was the most important facilitator. CONCLUSIONS This diagnosis provides a baseline for strengthening ASP implementation in the country's hospitals. National and institutional policies should prioritize targeting ASP planning, monitoring, and human resources allocation.
Collapse
Affiliation(s)
- Anahí Dreser
- Center for Health Systems Research, National Institute of Public Health, Av. Universidad 655, Cuernavaca, Morelos, Mexico.
| | - Jennifer Hegewisch-Taylor
- Center for Health Systems Research, National Institute of Public Health, Av. Universidad 655, Cuernavaca, Morelos, Mexico.
| | | | - Gabriel Levy-Hara
- Unit of Infectious Diseases, Hospital Carlos G Durand, Av. Díaz Vélez 5044, Buenos Aires, Argentina
| |
Collapse
|
2
|
Wagstaff D, Amuasi J, Arfin S, Aryal D, Nor MBM, Bonney J, Dondorp A, Dongelmans D, Dullawe L, Fazla F, Ghose A, Hanciles E, Haniffa R, Hashmi M, Smith AH, Kumar B, Minh YL, Moonesinghe R, Pisani L, Sendagire C, Hasan MS, Ghalib MS, Frimpong MS, Ranzani O, Sultan M, Thomson D, Tripathy S, Thwaites L, Uddin RAME, Mazlan MZ, Waweru-Siika W, Beane A. Evidence based QUality Improvement for Prescribing Stewardship in ICU (EQUIPS-ICU): protocol for type III hybrid implementation-effectiveness study. Implement Sci 2025; 20:12. [PMID: 40001051 PMCID: PMC11863957 DOI: 10.1186/s13012-024-01413-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2024] [Accepted: 12/23/2024] [Indexed: 02/27/2025] Open
Abstract
BACKGROUND Approximately half of all antimicrobial prescriptions in intensive care units (ICUs) may be inappropriate, including those prescribed when not needed, in unnecessary combinations or for longer durations than needed. Inappropriate prescribing is costly, exposes patients to unnecessary side-effects and drives population-level antimicrobial resistance, the prevalence and consequences of which are greatest in low- and middle-income countries. However, the implementation of interventions to improve the appropriateness of antimicrobial prescribing has been variable and requires further study. METHODS We propose a type III hybrid implementation/effectiveness interventional cohort trial in 35 ICUs in up to 11 low- and middle- income countries. The study intervention is a structured review of antimicrobial prescriptions as recommended by the World Health Organisation. Strategies to support stakeholder-led implementation include development of local protocols, registry-enabled audit and feedback, and education. Evaluation of implementation, and the determinants of its success, is informed by the RE-AIM framework and the Consolidated Framework for Implementation Research respectively. The primary outcome is a composite measure of fidelity, reach and adoption. Secondary outcomes describe the effectiveness of the intervention on improving antimicrobial prescribing. Qualitative interviews will assess relevant implementation acceptability, adaptations and maintenance. A baseline survey will investigate ICU-level antimicrobial stewardship structures and processes. DISCUSSION This study addresses global policy priorities by supporting implementation research of antimicrobial stewardship, and strengthening associated healthcare professional competencies. It does this in a setting where improvement is sorely needed: low- and middle- income country ICUs. The study will also describe the influence of pre-existing antimicrobial stewardship structures and processes on implementation and improve understanding about the efficacy of strategies to overcome barriers to implementation in these settings. TRIAL REGISTRATION This study protocol has been registered with ClinicalTrials.gov (ref NCT06666738) on 31 Oct 2004. https://clinicaltrials.gov/study/NCT06666738?term=NCT06666738&rank=1 .
Collapse
Affiliation(s)
- Duncan Wagstaff
- Centre for Preoperative Medicine, University College London, London, UK.
| | - John Amuasi
- Department of Global Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- Department of Implementation Research, Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany
- Global Health and Infectious Disease Research Group, KCCR, KNUST, Kumasi, Ghana
| | - Sumaiya Arfin
- The George Institute for Global Health, New Delhi, India
- Amsterdam Public Health (APH), Amsterdam University Medical Centre(UMC), Amsterdam, The Netherlands
- Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
| | - Diptesh Aryal
- Department of Critical Care, Nepal Intensive Care Research Foundation, Kathmandu, Nepal
| | - Mohd Basri Mat Nor
- Department of Intensive Care Anaesthesiology, International Islamic University Malaysia, Kuala Lumpur, Malaysia
| | - Joseph Bonney
- Emergency Medicine Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana
- Global Health and Infectious Disease Research Group, KCCR, KNUST, Kumasi, Ghana
| | - Arjen Dondorp
- Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
- Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - David Dongelmans
- National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands
- Department of Intensive Care Medicine, UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Layoni Dullawe
- Nat-Intensive Care Surveillance, Mahidol Oxford Tropical Medicine Research Unit, Colombo, Sri Lanka
| | - Fathima Fazla
- Nat-Intensive Care Surveillance, Mahidol Oxford Tropical Medicine Research Unit, Colombo, Sri Lanka
| | - Aniruddha Ghose
- Department of Medicine, Chittagong Medical College Hospital, Chattogram, Bangladesh
| | - Eva Hanciles
- Connaught Hospital, Freetown, Sierra Leone
- Ministry of Health and Sanitation, Freetown, Sierra Leone
| | - Rashan Haniffa
- Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
- Nat-Intensive Care Surveillance, Mahidol Oxford Tropical Medicine Research Unit, Colombo, Sri Lanka
- Pandemic Sciences Hub and Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| | - Madiha Hashmi
- Department of Critical Care Medicine, Ziauddin University, Karachi, Pakistan
| | - Adam Hewitt Smith
- Faculty of Health Sciences, Busitema University, Mbale, Uganda
- William Harvey Research Institute, Queen Mary University of London, London, UK
| | - Bharath Kumar
- Department of Critical Care Medicine, Apollo Hospitals Educational and Research Foundation, Chennai, India
| | - Yen Lam Minh
- Clinical Research Unit, Oxford University, University of Oxford, Ho Chi Minh City, Vietnam
| | | | - Luigi Pisani
- Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
| | - Cornelius Sendagire
- D'Or Institute for Research and Education, Sao Paulo, Brazil
- Uganda Heart Institute, University of Makerere, Makerere, Uganda
| | - Mohd Shahnaz Hasan
- Department of Intensive Care Anaesthesiology, International Islamic University Malaysia, Kuala Lumpur, Malaysia
| | | | - Moses Siaw Frimpong
- Department of Anaesthesiology and Intensive Care, Komfo Anokye Teaching Hospital, Kumasi, Ghana
| | - Otavio Ranzani
- Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
- Pulmonary Division, Heart Institute, Faculty of Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Menbeu Sultan
- Department of Emergency Medicine and Critical Care, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
| | - David Thomson
- Department of Anaesthesia and Perioperative Medicine, University of Cape Town, Cape Town, South Africa
| | - Swagata Tripathy
- Pandemic Sciences Hub and Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
- AII India Institute of Medical Sciences, New Delhi, India
| | - Louise Thwaites
- Clinical Research Unit, Oxford University, University of Oxford, Ho Chi Minh City, Vietnam
| | | | | | | | - Abigail Beane
- Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
- Nat-Intensive Care Surveillance, Mahidol Oxford Tropical Medicine Research Unit, Colombo, Sri Lanka
- Pandemic Sciences Hub and Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
3
|
Haque M, Karim MR, Shohid S, Choudhury SS, Hossain P, Sen RR, Dey C, Khan S, Munni MN, Shopna SA, Shultana R, Al Fidah MF, Khan MAS, Farhana N. Physician's perception and practices on antimicrobial resistance in a tertiary care hospital in Bangladesh: a cross-sectional study. BMJ Open 2024; 14:e087201. [PMID: 39806593 PMCID: PMC11667363 DOI: 10.1136/bmjopen-2024-087201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Accepted: 11/20/2024] [Indexed: 01/16/2025] Open
Abstract
BACKGROUND Antimicrobial resistance (AMR) is a global health and development concern. Antimicrobial misuse and overuse are key contributors to the emergence of drug-resistant infections. OBJECTIVE The current study aimed to determine the level of perception and practices of physicians regarding AMR in a tertiary-level hospital. DESIGN Cross-sectional study. SETTING A tertiary care hospital in Dhaka, Bangladesh. PARTICIPANTS The study included 360 physicians who worked for more than 6 months in different departments of the hospital. PRIMARY AND SECONDARY OUTCOME MEASURES Perceptions of AMR among physicians and secondary outcome measures were to find out the practices of physicians regarding AMR. The current study used 8 defined responses and 6 multiple-choice questions for scoring physicians' perception of AMR and 12 items to score physicians' self-reported practice regarding AMR. After converting these scores into percentages, the median split method was used to categorise them into poor and good categories. RESULTS Among 360 physicians, 51% were male, the median (IQR) age was 30 (27.0-34.0) years and 46% had private practices. More than half (52%) had a poor perception of AMR but had good practice (57%) with no significant association between perception and practice. The perception of AMR was significantly associated with age (p=0.048), years in practice (p=0.011) and AMR training (p=0.030). Physicians with private practice had 1.71 times higher odds of having a good perception of AMR (95% CI 2.07 to 2.75, p=0.026) and 2.44 times higher odds of having good practice (95% CI 1.51 to 3.94, p<0.001). The odds of having a good perception of AMR increase 1.20 times with a 1-year increase in years of practice (95% CI 1.01 to 1.44, p=0.042). CONCLUSION The study revealed that most physicians had poor perception but good practice regarding AMR. Both poor perception and good practice were associated with private practice. To increase good practice and perception regarding AMR, efforts need to be made to establish an AMR education programme for practicing physicians as soon as possible. Moreover, medical audits and continuous quality improvement (such as programmes for antimicrobial stewardship) should be legislated, and monitoring prescribing behaviour and formulating policies accordingly are the way forward in combating AMR.
Collapse
Affiliation(s)
- Mohibbul Haque
- National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| | | | - Sabrin Shohid
- National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| | - Shadman Sakib Choudhury
- Infectious Disease Division, International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh
| | - Pilot Hossain
- National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| | - Rotna Rani Sen
- National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| | - Chaity Dey
- National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| | - Sumaiya Khan
- National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| | | | | | - Razia Shultana
- National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| | - Md Fuad Al Fidah
- Nutrition Research Division, International Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh
| | | | - Nasreen Farhana
- Department of Microbiology and Mycology, National Institute of Preventive and Social Medicine, Dhaka, Bangladesh
| |
Collapse
|
4
|
Kumar V, Biswas R, Ojha VS, Kumar S, Sarfraz A. Efficacy of quality improvement interventions on antibiotic prescription practices for ventilator-associated pneumonia at a tertiary care centre: a prospective pre-post interventional study. BMJ Open Qual 2024; 13:e002926. [PMID: 39709191 PMCID: PMC11667312 DOI: 10.1136/bmjoq-2024-002926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2024] [Accepted: 12/05/2024] [Indexed: 12/23/2024] Open
Abstract
BACKGROUND Ventilator-associated pneumonia (VAP) is a prevalent nosocomial infection in the intensive care unit (ICU), significantly increasing patient morbidity, mortality, and healthcare costs. Effective management is essential, particularly in the context of antimicrobial resistance and the frequent use of antibiotics in ICUs. METHODS This prospective pre-post interventional study was conducted in the medical ICU of a tertiary care centre, over 6 months. Adult patients diagnosed with VAP and receiving antibiotics for more than 48 hours were included. The study involved three phases: preintervention (baseline antibiotic prescription audit), intervention (educational sessions, multidisciplinary meetings and tailored feedback) and postintervention (follow-up audit). Data analysis included Kaplan-Meier survival curves and statistical comparisons of ICU stay durations. RESULTS In the preintervention phase, the median treatment duration was 24 days, while the postintervention phase reduced this to 17 days. Kaplan-Meier curves showed improved survival probabilities and shorter ICU stays in the postintervention phase. The mean ICU stay decreased significantly from 24 days preintervention to 11.3 days postintervention (p=0.027). Mortality rates also improved, with 38.5% discharged and 61.5% deaths postintervention, compared with 23.5% discharged and 76.5% deaths preintervention. Antibiotic prescription patterns shifted towards more targeted therapy, adhering better to culture and sensitivity results and reducing the use of broad-spectrum antibiotics and polypharmacy. CONCLUSION Quality improvement interventions significantly improved VAP management by reducing treatment duration, ICU stay and mortality rates. Educational sessions, multidisciplinary collaboration and tailored feedback enhanced antibiotic prescription practices, highlighting the importance of continuous quality improvement in ICU settings. Further research and sustained efforts in antimicrobial stewardship are essential to combat VAP and improve patient outcomes.
Collapse
Affiliation(s)
- Vijay Kumar
- Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India
| | - Ratnadeep Biswas
- Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India
| | - Vishnu Shankar Ojha
- Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India
| | - Sanjeev Kumar
- Department of General Medicine, All India Institute of Medical Sciences, Patna, Bihar, India
| | - Asim Sarfraz
- Department of Microbiology, All India Institute of Medical Sciences, Patna, Bihar, India
| |
Collapse
|
5
|
Fabre V, Cosgrove SE, Lessa FC, Patel TS, Aleman WR, Aquiles B, Arauz AB, Barberis MF, Bangher MDC, Bernachea MP, Bernan ML, Blanco I, Cachafeiro A, Castañeda X, Castillo S, Colque AM, Contreras R, Cornistein W, Correa SM, Correal Tovar PC, Costilla Campero G, Esquivel C, Ezcurra C, Falleroni LA, Fernandez J, Ferrari S, Frassone N, Garcia Cruz C, Garzón MI, Gomez Quintero CH, Gonzalez JA, Guaymas L, Guerrero-Toapanta F, Lambert S, Laplume D, Lazarte PR, Lemir CG, Lopez A, Lopez IL, Martinez G, Maurizi DM, Melgar M, Mesplet F, Morales Pertuz C, Moreno C, Moya LG, Nuccetelli Y, Núñez G, Paez H, Palacio B, Pellice F, Pereyra ML, Pirra LS, Raffo CL, Reino Choto F, Vence Reyes L, Ricoy G, Rodriguez Gonzalez P, Rodriguez V, Romero F, Romero JJ, Sadino G, Sandoval N, Silva MG, Smud A, Soria V, Stanek V, Torralvo MJ, Urueña AM, Videla H, Valle M, Vera Amate Perez S, Vergara-Samur H, Villamandos S, Villarreal O, Viteri A, Warley E, Quiros RE. Antibiotic Use in Medical-Surgical Intensive Care Units and General Wards in Latin American Hospitals. Open Forum Infect Dis 2024; 11:ofae620. [PMID: 39494448 PMCID: PMC11530953 DOI: 10.1093/ofid/ofae620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2024] [Accepted: 10/09/2024] [Indexed: 11/05/2024] Open
Abstract
Background The objective of this study was to identify antibiotic stewardship (AS) opportunities in Latin American medical-surgical intensive care units (MS-ICUs) and general wards (Gral-wards). Methods We conducted serial cross-sectional point prevalence surveys in MS-ICUs and Gral-wards in 41 Latin American hospitals between March 2022 and February 2023. Patients >18 years of age in the units of interest were evaluated for antimicrobial use (AU) monthly (MS-ICUs) or quarterly (Gral-wards). Antimicrobial data were collected using a standardized form by the local AS teams and submitted to the coordinating team for analysis. Results We evaluated AU in 5780 MS-ICU and 7726 Gral-ward patients. The hospitals' median bed size (interquartile range) was 179 (125-330), and 52% were nonprofit. The aggregate AU prevalence was 53.5% in MS-ICUs and 25.5% in Gral-wards. Most (88%) antimicrobials were prescribed to treat infections, 7% for surgical prophylaxis and 5% for medical prophylaxis. Health care-associated infections led to 63% of MS-ICU and 38% of Gral-ward AU. Carbapenems, piperacillin-tazobactam, intravenous (IV) vancomycin, and ampicillin-sulbactam represented 50% of all AU to treat infections. A minority of IV vancomycin targeted therapy was associated with documented methicillin-resistant Staphylococcus aureus infection or therapeutic drug monitoring. In both units, 17% of antibiotics prescribed as targeted therapy represented de-escalation, while 24% and 15% in MS-ICUs and Gral-wards, respectively, represented an escalation of therapy. In Gral-wards, 32% of antibiotics were used without a microbiologic culture ordered. Half of surgical prophylaxis antibiotics were prescribed after the first 24 hours. Conclusions Based on this cohort, areas to improve AU in Latin American hospitals include antibiotic selection, de-escalation, duration of therapy, and dosing strategies.
Collapse
Affiliation(s)
- Valeria Fabre
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Sara E Cosgrove
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Fernanda C Lessa
- International Infection Control Branch, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Twisha S Patel
- International Infection Control Branch, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | | | - Bowen Aquiles
- Hospital Sociedad de Lucha Contra el Cáncer, Guayaquil, Ecuador
| | - Ana B Arauz
- Departamento de Medicina, Universidad de Panamá, Panama, Panama
- Hospital Santo Tomas, Panama, Panama
| | - Maria F Barberis
- Hospital Nacional Profesor Alejandro Posadas, El Palomar, Argentina
| | | | | | - Marisa L Bernan
- Hospital Interzonal General de Agudos San Roque, Buenos Aires, Argentina
| | - Isabel Blanco
- Pacifica Salud, Hospital Punta Pacifica, Panamá, Panama
| | | | - Ximena Castañeda
- Clínica De La Mujer, Bogotá, Colombia
- Hospital Mederi, Bogota, Colombia
| | | | - Angel M Colque
- Hospital Medico Policial Churruca Visca, Buenos Aires, Argentina
| | | | | | - Silvia Mabel Correa
- Hospital Municipal de Trauma Dr. Federico Abete, Malvinas Argentinas, Argentina
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Diego Laplume
- Hospital Nacional Profesor Alejandro Posadas, El Palomar, Argentina
| | - Paola R Lazarte
- Maternidad Nuestra Señora De Las Mercedes De Tucumán, Tucumán, Argentina
| | | | | | | | | | - Diego M Maurizi
- Hospital Municipal de Agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina
| | | | | | | | | | | | | | | | - Hugo Paez
- Hospital Simon Bolivar, Bogota, Colombia
| | | | | | | | - Luz S Pirra
- Hospital Privado Universitario de Córdoba, Córdoba, Argentina
| | - Carla Lorena Raffo
- Hospital Municipal de Trauma Dr. Federico Abete, Malvinas Argentinas, Argentina
| | | | | | - Gerardo Ricoy
- Hospital Medico Policial Churruca Visca, Buenos Aires, Argentina
| | | | | | | | | | - Graciela Sadino
- Clínica Universitaria Privada Reina Fabiola, Córdoba, Argentina
| | | | - Mirta G Silva
- Hospital Zonal General de Agudos Dr. Alberto Eurnekian, Buenos Aires, Argentina
| | - Astrid Smud
- Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | | - Vanina Stanek
- Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | | | - Alejandra M Urueña
- Maternidad Nuestra Señora De Las Mercedes De Tucumán, Tucumán, Argentina
| | - Hugo Videla
- Instituto de Diagnostico, La Plata, Argentina
| | - Marisol Valle
- Hospital Municipal de Agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina
| | | | | | - Silvina Villamandos
- Instituto de Cardiología de Corrientes “Juana Francisca Cabral,” Corrientes, Argentina
| | | | | | | | | |
Collapse
|
6
|
Custódio NS, Machado LF, Luckemeyer GD, Syrio JD, Frutuoso IS, Chanes DAV, Kaltenbacher LT, Braz MM, Nogueira MCL, Gandolfi JV, Lobo SM. Antibiotic stewardship and nosocomial infection prevention in critically ill patients: a quality improvement program. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (1992) 2024; 70:e20231282. [PMID: 38775503 PMCID: PMC11110964 DOI: 10.1590/1806-9282.20231282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Accepted: 01/19/2024] [Indexed: 05/24/2024]
Abstract
OBJECTIVE The objective of this study was to evaluate the impact of the implementation of a bundle of interventions through a "Program for Antibiotic Management and Nosocomial Infection Prevention" in the intensive care unit on antibiotic and devices use and healthcare-associated infections. METHODS This was a quasi-experimental study of consecutive series of cases in periods before and after the establishment of protocols and checklists for the use of antibiotics as well as other measures to prevent healthcare-associated infection as part of a quality improvement program. Antimicrobial consumption was assessed by the defined daily dose. RESULTS A total of 1,056 and 1,323 admissions in the pre-intervention and post-intervention phases, respectively, were evaluated. The defined daily dose per 100 patient-day decreased from 89±8 to 77±11 (p=0.100), with a decrease in carbapenems, glycopeptides, polymyxins, penicillins, and cephalosporins. The rates of ventilator and central venous catheter use decreased from 52.8 to 44.1% and from 76 to 70%, respectively. The rates of healthcare-associated infection decreased from 19.2 to 15.5%. CONCLUSION Quality improvement actions focused primarily on antimicrobial management and prevention of healthcare-associated infection are feasible and have the potential to decrease antibiotic use and healthcare-associated infection rates.
Collapse
Affiliation(s)
- Nayá Saad Custódio
- Faculty of Medicine of São José do Rio Preto – São José do Rio Preto (SP), Brazil
| | - Luana Fernandes Machado
- Hospital de Base de São José do Rio Preto, Faculty of Medicine of São José do Rio Preto, Intensive Care Unit – São José do Rio Preto (SP), Brazil
| | - Graziela Denardin Luckemeyer
- Hospital de Base de São José do Rio Preto, Faculty of Medicine of São José do Rio Preto, Intensive Care Unit – São José do Rio Preto (SP), Brazil
| | - Juliana Devós Syrio
- Hospital de Base de São José do Rio Preto, Faculty of Medicine of São José do Rio Preto, Intensive Care Unit – São José do Rio Preto (SP), Brazil
| | - Isabela Shumaher Frutuoso
- Hospital de Base de São José do Rio Preto, Faculty of Medicine of São José do Rio Preto, Intensive Care Unit – São José do Rio Preto (SP), Brazil
| | - Debora Augusto Valverde Chanes
- Hospital de Base de São José do Rio Preto, Faculty of Medicine of São José do Rio Preto, Intensive Care Unit – São José do Rio Preto (SP), Brazil
| | - Luciana Tirelli Kaltenbacher
- Comissão de Controle de Infecção Hospitalar, Hospital de Base de São José do Rio Preto, Faculdade de Medicina de São José do Rio Preto – São José do Rio Preto (SP), Brazil
| | - Melissa Maia Braz
- Comissão de Controle de Infecção Hospitalar, Hospital de Base de São José do Rio Preto, Faculdade de Medicina de São José do Rio Preto – São José do Rio Preto (SP), Brazil
| | | | | | | |
Collapse
|
7
|
Portela de Assis M, Ziembowicz H, Mosmann Menezes R, Santos Gonçalves MR, Machado de Miranda Costa M, Carneiro M. Stewardship in Brazil: A Call for Action. Clin Infect Dis 2024; 78:1073-1075. [PMID: 37816149 DOI: 10.1093/cid/ciad624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2023] [Revised: 09/12/2023] [Accepted: 10/06/2023] [Indexed: 10/12/2023] Open
Affiliation(s)
- Mariana Portela de Assis
- Santa Cruz Hospital Pharmacy Service, Santa Cruz do Sul, Rio Grande do Sul, Brazil
- Department of Health Sciences, Postgraduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul, Rio Grande do Sul, Brazil
| | - Henrique Ziembowicz
- Department of Health Science, Division of Medicine, University of Santa Cruz do Sul, Rio Grande do Sul, Brazil
| | - Rochele Mosmann Menezes
- Santa Cruz Hospital Pharmacy Service, Santa Cruz do Sul, Rio Grande do Sul, Brazil
- Department of Health Sciences, Postgraduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul, Rio Grande do Sul, Brazil
| | - Mara Rubia Santos Gonçalves
- National Health Surveillance Agency, Health Services Surveillance and Monitoring and Health Services Technology Management, Brasília, Distrito Federal, Brazil
| | - Magda Machado de Miranda Costa
- National Health Surveillance Agency, Health Services Surveillance and Monitoring and Health Services Technology Management, Brasília, Distrito Federal, Brazil
| | - Marcelo Carneiro
- Santa Cruz Hospital Pharmacy Service, Santa Cruz do Sul, Rio Grande do Sul, Brazil
- Department of Health Sciences, Postgraduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul, Rio Grande do Sul, Brazil
- Department of Health Science, Division of Medicine, University of Santa Cruz do Sul, Rio Grande do Sul, Brazil
- Brazilian Association of Professionals in Infection Control and Hospital Epidemiology (ABIH), Brazil
| |
Collapse
|
8
|
Fernandes RDA, Carneiro M, Makdisse M, Adiwardana NS, Telles JP, Vidal CFDL, Cotia ALF, Gray M. The Brazilian collaborative on antimicrobial stewardship: A value-based healthcare approach. Braz J Infect Dis 2024; 28:103738. [PMID: 38679060 PMCID: PMC11070586 DOI: 10.1016/j.bjid.2024.103738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Revised: 02/27/2024] [Accepted: 04/14/2024] [Indexed: 05/01/2024] Open
Affiliation(s)
| | - Marcelo Carneiro
- Universidade de Santa Cruz do Sul, Rio Grande do Sul, RS, Brazil
| | | | | | | | | | | | - Muir Gray
- Oxford Value and Stewardship Programme (OVSP) & Academia VBHC, Oxford, UK
| |
Collapse
|
9
|
Büchler AC, Haddad Galas M, Buetti N, Alp E, Apisarnthanarak A, Dziekan G, Fabre V, Gottwalt S, Jindai K, Ndoye B, Márquez Villareal H, Otaiza F, Pittet D, Schellack N, Gardiol C, Harbarth S. Challenges and success stories of the implementation of infection control and antimicrobial stewardship strategies: proceedings of the 5th Global Ministerial Summit on Patient Safety, 2023. Antimicrob Resist Infect Control 2024; 13:16. [PMID: 38331974 PMCID: PMC10854024 DOI: 10.1186/s13756-023-01344-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Accepted: 11/25/2023] [Indexed: 02/10/2024] Open
Abstract
The 5th edition of the Global Ministerial Summit on Patient Safety was held in Montreux, Switzerland, in February 2023, delayed by three years due to the COVID-19 pandemic. The overarching theme of the summit was "Less Harm, Better Care - from Resolution to Implementation", focusing on the challenges of implementation of infection prevention and control (IPC) strategies as well as antimicrobial stewardship programs (ASP) around the world. IPC strategies and ASP are of increasing importance due to the substantial burden of healthcare-associated infections and antimicrobial resistance threatening patient safety. Here, we summarize countries' and regional experiences and activities related to the implementation of IPC strategies and ASP shared at the meeting. Full implementation of effective programs remains a major challenge in all settings due to limited support by political and healthcare leaders, and human and financial constraints. In addition, the COVID-19 pandemic challenged already well-established programs. By enforcing sustained implementation by dedicated, cross-disciplinary healthcare personnel with a broad skill set, a reduction in healthcare-associated infections and multidrug-resistant pathogens can be achieved, leading ultimately to improved patient safety.
Collapse
Affiliation(s)
- Andrea C Büchler
- Infection Control Program, Faculty of Medicine, Geneva University Hospitals, WHO Collaborating Center, Rue Gabrielle-Perret-Gentil 4, Genève, 1205, Switzerland
| | - Murielle Haddad Galas
- Infection Control Program, Faculty of Medicine, Geneva University Hospitals, WHO Collaborating Center, Rue Gabrielle-Perret-Gentil 4, Genève, 1205, Switzerland
| | - Niccolò Buetti
- Infection Control Program, Faculty of Medicine, Geneva University Hospitals, WHO Collaborating Center, Rue Gabrielle-Perret-Gentil 4, Genève, 1205, Switzerland
- IAME UMR 1137, INSERM, Université Paris-Cité, Paris, France
| | - Emine Alp
- Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Türkiye
| | - Anucha Apisarnthanarak
- Division of Infectious Diseases, Faculty of Medicine, Thammasat University Hospital, Pathum Thani, Thailand
| | - Gerald Dziekan
- Communicable Disease Division, Federal Office of Public Health FOPH, Bern, Switzerland
| | - Valeria Fabre
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, USA
| | - Simon Gottwalt
- Communicable Disease Division, Federal Office of Public Health FOPH, Bern, Switzerland
| | - Kazuaki Jindai
- Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan
- Department of Healthcare Epidemiology, School of Public Health, Kyoto University, Kyoto, Japan
| | - Babacar Ndoye
- Infection Control and Patient Safety, WHO Afro Consultant, Brazzaville, Congo Republic
| | - Hilda Márquez Villareal
- Department of Public Health. University Center of Health Sciences, University of Guadalajara, Guadalajara, Mexico
| | - Fernando Otaiza
- Department of Quality of Healthcare and Patient Safety, National Infection Control Program, Ministry of Health of Chile, Santiago, Chile
| | - Didier Pittet
- Infection Control Program, Faculty of Medicine, Geneva University Hospitals, WHO Collaborating Center, Rue Gabrielle-Perret-Gentil 4, Genève, 1205, Switzerland
| | - Natalie Schellack
- Departement of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
| | - Céline Gardiol
- Communicable Disease Division, Federal Office of Public Health FOPH, Bern, Switzerland
| | - Stephan Harbarth
- Infection Control Program, Faculty of Medicine, Geneva University Hospitals, WHO Collaborating Center, Rue Gabrielle-Perret-Gentil 4, Genève, 1205, Switzerland.
| |
Collapse
|
10
|
Riera F, Cortes Luna J, Rabagliatti R, Scapellato P, Caeiro JP, Chaves Magri MM, Sotomayor CE, Rodrigues Falci D. Antifungal stewardship: the Latin American experience. ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY : ASHE 2023; 3:e217. [PMID: 38156226 PMCID: PMC10753509 DOI: 10.1017/ash.2023.471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Revised: 09/20/2023] [Accepted: 09/21/2023] [Indexed: 12/30/2023]
Abstract
Antifungal stewardship is a critical component of healthcare management that focuses on optimizing the use of antifungal medications to improve patient outcomes, minimize resistance, and reduce healthcare costs. In resource-limited settings, the prevalence of fungal infections remains a significant health concern, often exacerbated by factors such as compromised immune systems, inadequate diagnostic capabilities, and limited access to antifungal agents. This paper reviews the current state of antifungal stewardship practices in developing countries, addressing the unique socioeconomic and healthcare landscape.
Collapse
Affiliation(s)
- Fernando Riera
- Division of Infectious Diseases, Sanatorio Allende Córdoba, Córdoba, Argentina
- Infectious Diseases, Universidad Nacional de Córdoba, Córdoba, Argentina
| | - Jorge Cortes Luna
- Medicine Department of Internal Medicine School of Medicine, Universidad Nacional de Colombia, Colombia
| | - Ricardo Rabagliatti
- Departamento de Enfermedades Infecciosas del Adulto, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Pablo Scapellato
- Chief Infectious Diseases Unit, Hospital D.F. Santojanni, Medicina Universidad Favaloro, Argentina
| | - Juan Pablo Caeiro
- HIV/Infectious Diseases Services at AltaMed, Infectious Diseases, Universidad Nacional de Córdoba, Córdoba, Argentina
| | - Marcello Mihalenko Chaves Magri
- Infectious Diseases Services, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
| | - Claudia Elena Sotomayor
- CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Laboratory of Innate Immunity to Fungal Pathogens, Córdoba, Argentina
- Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina
| | - Diego Rodrigues Falci
- Infectious Diseases Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
- Infectious Diseases at the School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
| |
Collapse
|
11
|
Zurita J, Sevillano G, Paz Y Miño A, Haro N, Larrea-Álvarez M, Alcocer I, Ortega-Paredes D. Dominance of ST131, B2, blaCTX-M-15, and papA-papC-kpsMII-uitA among ESBL Escherichia coli isolated from bloodstream infections in Quito, Ecuador: a 10-year surveillance study (2009-2019). J Appl Microbiol 2023; 134:lxad269. [PMID: 37974051 DOI: 10.1093/jambio/lxad269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 09/21/2023] [Accepted: 11/15/2023] [Indexed: 11/19/2023]
Abstract
AIMS This study aimed to examine antibiotic resistance and the epidemiology of extended-spectrum β-lactamases (ESBL)-producing Escherichia coli associated with bloodstream infections over a period of 10 years. METHODS AND RESULTS Isolates were collected from January 2009 to December 2019 and those testing for E. coli were included. Antibiotic susceptibility was tested using the VITEK® system. Selected isolates were further characterized by amplification of marker genes (virulence traits, phylogroups, and sequence types). A total of 166 ESBL-producing E. coli were recovered. The blaCTX-M-15 allele was the most abundant. Most of the isolates were resistant to ceftriaxone, cefepime, ceftazidime, ampicillin/sulbactam, piperacillin/tazobactam, and ciprofloxacin. No resistance to carbapenems was registered. More than 80% of bacteria were classified as extraintestinal pathogenic E. coli (ExPEC), and the combination of virulence traits:papA-papC-kpsMII-uitA was the most common. Phylogroup B2 was the most prevalent, and bacteria predominantly belonged to ST131. CONCLUSIONS There was an increase in the ExPEC ESBL-E coli in bloodstream infections and the relationship between the isolates found in these infections during these 10 years.
Collapse
Affiliation(s)
- Jeannete Zurita
- Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito 170525, Ecuador
- Unidad de Investigaciones en Biomedicina, Zurita & Zurita Laboratorios, Quito 170104, Ecuador
- Servicio de Microbiología y Tuberculosis, Hospital Vozandes, Quito 170521, Ecuador
| | - Gabriela Sevillano
- Unidad de Investigaciones en Biomedicina, Zurita & Zurita Laboratorios, Quito 170104, Ecuador
| | - Ariane Paz Y Miño
- Unidad de Investigaciones en Biomedicina, Zurita & Zurita Laboratorios, Quito 170104, Ecuador
| | - Nathalí Haro
- Unidad de Investigaciones en Biomedicina, Zurita & Zurita Laboratorios, Quito 170104, Ecuador
| | - Marco Larrea-Álvarez
- Facultad de Ciencias Médicas Enrique Ortega Moreira, Carrera de Medicina, Universidad Espíritu Santo, Km 2.5 vía a Samborondón 0901952, Ecuador
| | - Iliana Alcocer
- Escuela de Ciencias Biológicas, Pontificia Universidad Católica del Ecuador, Quito 170525, Ecuador
| | - David Ortega-Paredes
- Facultad de Ciencias Médicas Enrique Ortega Moreira, Carrera de Medicina, Universidad Espíritu Santo, Km 2.5 vía a Samborondón 0901952, Ecuador
- Unidad de Investigación en Enfermedades Transmitidas por Alimentos y Resistencia a los, Antimicrobianos (UNIETAR), Facultad de Veterinaria, Universidad Central del Ecuador, Quito 170129, Ecuador
- Laboratorio de Referencia de E. coli, Department of Microbiology and Parasitology, Veterinary Faculty, University of Santiago de Compostela, Lugo 15782, Spain
| |
Collapse
|
12
|
Díaz-Madriz JP, Zavaleta-Monestel E, Villalobos-Madriz JA, Rojas-Chinchilla C, Castrillo-Portillo P, Meléndez-Alfaro A, Vásquez-Mendoza AF, Muñoz-Gutiérrez G, Arguedas-Chacón S. Impact of the Five-Year Intervention of an Antimicrobial Stewardship Program on the Optimal Selection of Surgical Prophylaxis in a Hospital without Antibiotic Prescription Restrictions in Costa Rica: A Retrospective Study. Antibiotics (Basel) 2023; 12:1572. [PMID: 37998774 PMCID: PMC10668641 DOI: 10.3390/antibiotics12111572] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 10/25/2023] [Accepted: 10/26/2023] [Indexed: 11/25/2023] Open
Abstract
This study aims to characterize the impact of the implementation of an antimicrobial stewardship program (AMS) on the optimal selection of surgical antibiotic prophylaxis in adult patients. This is a retrospective quasi-experimental study that compared the selection and duration of antibiotics for all surgical prophylaxis prescriptions over six months, both before (pre-AMS) and after a five-year intervention of AMS (post-AMS). In addition, data related to the consumption of antibiotics, adverse drug reactions, and surgical site infections throughout the years of the intervention were analyzed. The rate of appropriate selection of antibiotic prophylaxis in surgical procedures improved to 80% during the post-AMS period. The percentage of optimal duration increased from 69.1% (N = 1598) in the pre-AMS period to 78.0% (N = 841) in the post-AMS period (p < 0.001). The consumption of ceftriaxone significantly decreased, while the use of cefazolin increased more than nine times. No severe adverse reactions or increases in surgical site infections were detected after the intervention. The implementation of an AMS in the surgical ward demonstrated a trend towards a positive overall impact on the selection and duration of prophylactic antibiotics for surgery, with positive results also observed in other variables associated with the prescription of these antibiotics.
Collapse
Affiliation(s)
- José Pablo Díaz-Madriz
- Pharmacy Department, Hospital Clínica Bíblica, San José 10104, Costa Rica; (J.P.D.-M.); (J.A.V.-M.); (C.R.-C.); (S.A.-C.)
- Faculty of Pharmacy, Universidad de Ciencias Médicas, San José 10108, Costa Rica; (P.C.-P.); (A.M.-A.)
- Antimicrobial Stewardship Program, Hospital Clínica Bíblica, San José 10104, Costa Rica; (A.F.V.-M.); (G.M.-G.)
| | - Esteban Zavaleta-Monestel
- Pharmacy Department, Hospital Clínica Bíblica, San José 10104, Costa Rica; (J.P.D.-M.); (J.A.V.-M.); (C.R.-C.); (S.A.-C.)
| | - Jorge Arturo Villalobos-Madriz
- Pharmacy Department, Hospital Clínica Bíblica, San José 10104, Costa Rica; (J.P.D.-M.); (J.A.V.-M.); (C.R.-C.); (S.A.-C.)
- Faculty of Pharmacy, Universidad de Ciencias Médicas, San José 10108, Costa Rica; (P.C.-P.); (A.M.-A.)
| | - Carolina Rojas-Chinchilla
- Pharmacy Department, Hospital Clínica Bíblica, San José 10104, Costa Rica; (J.P.D.-M.); (J.A.V.-M.); (C.R.-C.); (S.A.-C.)
- Antimicrobial Stewardship Program, Hospital Clínica Bíblica, San José 10104, Costa Rica; (A.F.V.-M.); (G.M.-G.)
| | | | - Alison Meléndez-Alfaro
- Faculty of Pharmacy, Universidad de Ciencias Médicas, San José 10108, Costa Rica; (P.C.-P.); (A.M.-A.)
| | | | - Gabriel Muñoz-Gutiérrez
- Antimicrobial Stewardship Program, Hospital Clínica Bíblica, San José 10104, Costa Rica; (A.F.V.-M.); (G.M.-G.)
| | - Sebastián Arguedas-Chacón
- Pharmacy Department, Hospital Clínica Bíblica, San José 10104, Costa Rica; (J.P.D.-M.); (J.A.V.-M.); (C.R.-C.); (S.A.-C.)
- Antimicrobial Stewardship Program, Hospital Clínica Bíblica, San José 10104, Costa Rica; (A.F.V.-M.); (G.M.-G.)
| |
Collapse
|
13
|
Ture Z, Güner R, Alp E. Antimicrobial stewardship in the intensive care unit. JOURNAL OF INTENSIVE MEDICINE 2023; 3:244-253. [PMID: 37533805 PMCID: PMC10391567 DOI: 10.1016/j.jointm.2022.10.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Revised: 10/03/2022] [Accepted: 10/10/2022] [Indexed: 08/04/2023]
Abstract
High resistance rates to antimicrobials continue to be a global health threat. The incidence of multidrug-resistant (MDR) microorganisms in intensive care units (ICUs) is quite high compared to in the community and other units in the hospital because ICU patients are generally older, have higher numbers of co-morbidities and immune-suppressed; moreover, the typically high rates of invasive procedures performed in the ICU increase the risk of infection by MDR microorganisms. Antimicrobial stewardship (AMS) refers to the implementation of coordinated interventions to improve and track the appropriate use of antibiotics while offering the best possible antibiotic prescription (according to dose, duration, and route of administration). Broad-spectrum antibiotics are frequently preferred in ICUs because of greater infection severity and colonization and infection by MDR microorganisms. For this reason, a number of studies on AMS in ICUs have increased in recent years. Reducing the use of broad-spectrum antibiotics forms the basis of AMS. For this purpose, parameters such as establishing an AMS team, limiting the use of broad-spectrum antimicrobials, terminating treatments early, using early warning systems, pursuing infection control, and providing education and feedback are used. In this review, current AMS practices in ICUs are discussed.
Collapse
Affiliation(s)
- Zeynep Ture
- Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri 38039,Turkey
| | - Rahmet Güner
- Department of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University, Ankara 06800, Turkey
| | - Emine Alp
- Department of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University, Ankara 06800, Turkey
| |
Collapse
|
14
|
Fabre V, Secaira C, Cosgrove SE, Lessa FC, Patel TS, Alvarez AA, Anchiraico LM, del Carmen Bangher M, Barberis MF, Burokas MS, Castañeda X, Colque AM, De Ascencao G, Esquivel C, Ezcurra C, Falleroni LA, Frassone N, Garzón MI, Gomez C, Gonzalez JA, Hernandez D, Laplume D, Lemir CG, Maldonado Briones H, Melgar M, Mesplet F, Martinez G, Pertuz CM, Moreno C, Nemirovsky C, Nuccetelli Y, Palacio B, Sandoval N, Vergara H, Videla H, Villamandos S, Villareal O, Viteri A, Quiros R. Deep Dive Into Gaps and Barriers to Implementation of Antimicrobial Stewardship Programs in Hospitals in Latin America. Clin Infect Dis 2023; 77:S53-S61. [PMID: 37406044 PMCID: PMC10321692 DOI: 10.1093/cid/ciad184] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/07/2023] Open
Abstract
BACKGROUND Antimicrobial resistance has worsened in Latin America. There is an urgent need to understand the development of antimicrobial stewardship programs (ASPs) and the barriers to implementing effective ASPs in light of limited national action plans or policies to promote ASPs in the region. METHODS We performed a descriptive mixed-methods study of ASPs in 5 Latin American countries in March-July 2022. An electronic questionnaire with an associated scoring system (hospital ASP self-assessment) was used, and ASP development was classified based on the scores (inadequate, 0-25; basic, 26-50; intermediate, 51-75; or advanced, 76-100). Interviews among healthcare workers (HCWs) involved in antimicrobial stewardship (AS) inquired about behavioral and organizational factors that influence AS activities. Interview data were coded into themes. Results from the ASP self-assessment and interviews were integrated to create an explanatory framework. RESULTS Twenty hospitals completed the self-assessment, and 46 AS stakeholders from these hospitals were interviewed. ASP development was inadequate/basic in 35% of hospitals, intermediate in 50%, and advanced in 15%. For-profit hospitals had higher scores than not-for-profit hospitals. Interview data validated the self-assessment findings and provided further insight into ASP implementation challenges, which included limited formal hospital leadership support, inadequate staffing and tools to perform AS work more efficiently, limited awareness of AS principles by HCWs, and limited training opportunities. CONCLUSIONS We identified several barriers to ASP development in Latin America, suggesting the need to create accurate business cases for ASPs to obtain the necessary funding for their effective implementation and sustainability.
Collapse
Affiliation(s)
- Valeria Fabre
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Clara Secaira
- Department of Anthropology and Sociology, Universidad del Valle, Guatemala City, Guatemala
| | - Sara E Cosgrove
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Fernanda C Lessa
- International Infection Control Program, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Twisha S Patel
- International Infection Control Program, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | | | | | | | | | | | | | - Angel M Colque
- Hospital Complejo Medico Churruca Visca, Buenos Aires, Argentina
| | | | | | | | | | - Natalia Frassone
- Unidad de Cirugía Cardiovascular de Guatemala, Guatemala City, Guatemala
| | | | - Carlos Gomez
- Clínica De La Mujer, Bogota, Colombia
- Hospital Militar Central San José Centro, Bogota, Colombia
| | | | | | - Diego Laplume
- Hospital Nacional Profesor Alejandro Posadas, El Palomar, Argentina
| | | | | | | | | | | | | | | | | | | | | | | | - Hernan Vergara
- Hospital Militar Central San José Centro, Bogota, Colombia
| | - Hugo Videla
- Instituto de Diagnostico, La Plata, Argentina
| | - Silvina Villamandos
- Instituto de Cardiología de Corrientes Juana Francisca Cabral, Corrientes, Argentina
| | | | | | - Rodolfo Quiros
- PROAnet Project Lead and Sanatorio Las Lomas, Buenos Aires, Argentina
| |
Collapse
|
15
|
Hassan SK, Dahmash EZ, Madi T, Tarawneh O, Jomhawi T, Alkhob W, Ghanem R, Halasa Z. Four years after the implementation of antimicrobial stewardship program in Jordan: evaluation of program's core elements. Front Public Health 2023; 11:1078596. [PMID: 37325334 PMCID: PMC10262748 DOI: 10.3389/fpubh.2023.1078596] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Accepted: 05/09/2023] [Indexed: 06/17/2023] Open
Abstract
Objectives To combat antimicrobial resistance, the World Health Organization (WHO) urged healthcare organizations in Low- and Middle-Income Countries (LMICs) to implement the core elements of the antimicrobial stewardship (AMS) programs. In response, Jordan took action and developed a national antimicrobial resistance action plan (NAP) in 2017 and commenced the AMS program in all healthcare facilities. It is paramount to evaluate the efforts to implement the AMS programs and understand the challenges of implementing a sustainable and effective program, in Low-Middle Income Country (LMIC) contexts. Therefore, the aim of this study was to appraise the compliance of public hospitals in Jordan to the WHO core elements of effective AMS programs after 4 years of commencement. Methods A cross-sectional study in public hospitals in Jordan, using the WHO AMS program core elements for LMICs was carried out. The questionnaire comprised 30 questions that covered the program's six core elements: leadership commitment, accountability and responsibility, AMS actions, education and training, monitoring, and evaluation, and reporting and feedback. A five-point Likert scale was employed for each question. Results A total of 27 public hospitals participated, with a response rate of 84.4%. Adherence to core elements ranged from (53%) in the leadership commitment domain to (72%) for AMS procedure application (actions). Based on the mean score, there was no significant difference between hospitals according to location, size, and specialty. The most neglected core elements that emerged as top priority areas were the provision of financial support, collaboration, access, as well as monitoring and evaluation. Conclusion The current results revealed significant shortcomings in the AMS program in public hospitals despite 4 years of implementation and policy support. Most of the core elements of the AMS program were below average, which requires hospital leadership commitment, and multifaceted collaborative actions from the concerned stakeholders in Jordan.
Collapse
Affiliation(s)
- Samar Khaled Hassan
- Department of Accreditation, Healthcare Accreditation Council, Amman, Jordan
| | - Eman Zmaily Dahmash
- Department of Chemical and Pharmaceutical Sciences, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, United Kingdom
| | - Thaira Madi
- Department of Accreditation, Healthcare Accreditation Council, Amman, Jordan
| | - Omar Tarawneh
- Department of Consultation, Healthcare Accreditation Council, Amman, Jordan
| | - Tuqa Jomhawi
- Department of Accreditation, Healthcare Accreditation Council, Amman, Jordan
| | - Worood Alkhob
- Department of Accreditation, Healthcare Accreditation Council, Amman, Jordan
| | - Rola Ghanem
- Laboratory Directorate, Ministry of Health, Amman, Jordan
| | - Zina Halasa
- Clinical Pharmacy Directorate, Ministry of Health, Amman, Jordan
| |
Collapse
|
16
|
Yock-Corrales A, Naranjo-Zuñiga G. Regional Perspective of Antimicrobial Stewardship Programs in Latin American Pediatric Emergency Departments. Antibiotics (Basel) 2023; 12:antibiotics12050916. [PMID: 37237820 DOI: 10.3390/antibiotics12050916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Revised: 05/06/2023] [Accepted: 05/13/2023] [Indexed: 05/28/2023] Open
Abstract
Antibiotic stewardship (AS) programs have become a priority for health authorities to reduce the number of infections by super-resistant microorganisms. The need for these initiatives to minimize the inadequate use of antimicrobials is essential, and the election of the antibiotic in the emergency department usually impacts the choice of treatment if the patients need hospital admission, becoming an opportunity for antibiotic stewardship. In the pediatric population, broad-spectrum antibiotics are more likely to be overprescribed without any evidence-based management, and most of the publications have focused on the prescription of antibiotics in ambulatory settings. Antibiotic stewardship efforts in pediatric emergency departments in Latin American settings are limited. The lack of literature on AS programs in the pediatric emergency departments in Latin America (LA) limits the information available. The aim of this review was to give a regional perspective on how pediatric emergency departments in LA are working towards antimicrobial stewardship.
Collapse
Affiliation(s)
- Adriana Yock-Corrales
- Emergency Department, Hospital Nacional de Niños "Dr. Carlos Saenz Herrera", Caja Costarricense del Seguro Social (CCSS), San José P.O. Box 1654-1000, Costa Rica
| | - Gabriela Naranjo-Zuñiga
- Infectious Disease Department, Hospital Nacional de Niños "Dr. Carlos Saenz Herrera", Caja Costarricense del Seguro Social (CCSS), San José P.O. Box 1654-1000, Costa Rica
| |
Collapse
|
17
|
Fabre V, Cosgrove SE, Secaira C, Tapia Torrez JC, Lessa FC, Patel TS, Quiros R. Antimicrobial stewardship in Latin America: Past, present, and future. ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY : ASHE 2022; 2:e68. [PMID: 36483374 PMCID: PMC9726506 DOI: 10.1017/ash.2022.47] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Revised: 03/16/2022] [Accepted: 03/21/2022] [Indexed: 06/01/2023]
Abstract
Implementation of antimicrobial stewardship programs (ASPs) in well-resourced countries has been associated with reductions in antibiotic-resistant infections and improved patient outcomes. Several guidance documents providing recommendations on how to structure antimicrobial stewardship activities at the national and hospital level in resource-limited settings have been published. However, few hospitals in Latin America report having a structure or resources needed for a successful ASP. Given the alarming increases in antimicrobial resistance in Latin America, better understanding of barriers to promote implementation of effective ASPs is urgently needed. We have summarized past and present antimicrobial stewardship activities in Latin American hospitals, and we describe key elements needed in future efforts to strengthen antimicrobial stewardship in the region.
Collapse
Affiliation(s)
- Valeria Fabre
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
| | - Sara E. Cosgrove
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
| | | | | | - Fernanda C. Lessa
- International Infection Control Program, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
| | - Twisha S. Patel
- International Infection Control Program, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
| | | |
Collapse
|
18
|
Pérez-Lazo G, Abarca-Salazar S, Lovón R, Rojas R, Ballena-López J, Morales-Moreno A, Flores-Paredes W, Arenas-Ramírez B, Illescas LR. Antibiotic Consumption and Its Relationship with Bacterial Resistance Profiles in ESKAPE Pathogens in a Peruvian Hospital. Antibiotics (Basel) 2021; 10:antibiotics10101221. [PMID: 34680802 PMCID: PMC8532675 DOI: 10.3390/antibiotics10101221] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Revised: 10/01/2021] [Accepted: 10/03/2021] [Indexed: 11/16/2022] Open
Abstract
A descriptive design was carried out studying the correlation between antimicrobial consumption and resistance profiles of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) in a Peruvian hospital, including the surgical, clinical areas and the intensive care unit (ICU) during the time period between 2015 and 2018. There was a significant correlation between using ceftazidime and the increase of carbapenem-resistant Pseudomonas aeruginosa isolations (R = 0.97; p < 0.05) and the resistance to piperacillin/tazobactam in Enterobacter spp. and ciprofloxacin usage (R = 0.97; p < 0.05) in the medical wards. The Pseudomonas aeruginosa resistance to piperacillin/tazobactam and amikacin in the intensive care unit (ICU) had a significant reduction from 2015 to 2018 (67% vs. 28.6%, 65% vs. 34.9%, p < 0.001). These findings give valuable information about the rates and dynamics in the relationship between antibiotic usage and antimicrobial resistance patterns in a Peruvian hospital and reinforce the need for continuous support and assessment of antimicrobial stewardship strategies, including microbiological indicators and antimicrobial consumption patterns.
Collapse
Affiliation(s)
- Giancarlo Pérez-Lazo
- Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru; (J.B.-L.); (A.M.-M.)
- Correspondence: (G.P.-L.); (L.R.I.)
| | - Susan Abarca-Salazar
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK;
| | - Renata Lovón
- Hospital Pharmacy Unit, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru; (R.L.); (R.R.)
| | - Rocío Rojas
- Hospital Pharmacy Unit, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru; (R.L.); (R.R.)
| | - José Ballena-López
- Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru; (J.B.-L.); (A.M.-M.)
| | - Adriana Morales-Moreno
- Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru; (J.B.-L.); (A.M.-M.)
| | - Wilfredo Flores-Paredes
- Clinical Pathology Department, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru;
| | - Berenice Arenas-Ramírez
- Infection Prevention and Control Unit, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru;
| | - Luis Ricardo Illescas
- Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru; (J.B.-L.); (A.M.-M.)
- Correspondence: (G.P.-L.); (L.R.I.)
| |
Collapse
|
19
|
Perspectives of Healthcare Professionals Regarding Factors Associated with Antimicrobial Resistance (AMR) and Their Consequences: A Cross Sectional Study in Eastern Province of Saudi Arabia. Antibiotics (Basel) 2021; 10:antibiotics10070878. [PMID: 34356799 PMCID: PMC8300731 DOI: 10.3390/antibiotics10070878] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Revised: 07/07/2021] [Accepted: 07/08/2021] [Indexed: 11/23/2022] Open
Abstract
Factors reported in the literature associated with inappropriate prescribing of antimicrobials include physicians with less experience, uncertain diagnosis, and patient caregiver influences on physicians’ decisions. Monitoring antimicrobial resistance is critical for identifying emerging resistance patterns, developing, and assessing the effectiveness of mitigation strategies. Improvement in prescribing antimicrobials would minimize the risk of resistance and, consequently, improve patients’ clinical and health outcomes. The purpose of the study is to delineate factors associated with antimicrobial resistance, describe the factors influencing prescriber’s choice during prescribing of antimicrobial, and examine factors related to consequences of inappropriate prescribing of antimicrobial. A cross-sectional study was conducted among healthcare providers (190) in six tertiary hospitals in the Eastern province of Saudi Arabia. The research panel has developed, validated, and piloted survey specific with closed-ended questions. A value of p < 0.05 was considered to be statistically significant. All data analysis was performed using the Statistical Package for Social Sciences (IBM SPSS version 23.0). 72.7% of the respondents have agreed that poor skills and knowledge are key factors that contribute to the inappropriate prescribing of antimicrobials. All of the respondents acknowledged effectiveness, previous experience with the antimicrobial, and reading scientific materials (such as books, articles, and the internet) as being key factors influencing physicians’ choice during antimicrobial prescribing. The current study has identified comprehensive education and training needs for healthcare providers about antimicrobial resistance. Using antimicrobials unnecessarily, insufficient duration of antimicrobial use, and using broad spectrum antimicrobials were reported to be common practices. Furthermore, poor skills and knowledge were a key factor that contributed to the inappropriate use and overuse of antimicrobials, and the use of antimicrobials without a physician’s prescription (i.e., self-medication) represent key factors which contribute to AMR from participants’ perspectives. Furthermore, internal policy and guidelines are needed to ensure that the antimicrobials are prescribed in accordance with standard protocols and clinical guidelines.
Collapse
|